Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AF8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,438
Award facts
- Contract value 100% obligated
- $12,438.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $12,438.15 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price delivery order is scheduled for completion by February 10, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitively awarded basis, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026. That comprehensive IDC functions as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Tagrisso, a specialty oncology medication, represents the type of critical therapeutic pharmaceutical products that AmerisourceBergen routinely delivers under this expansive contract vehicle to support Defense Health Agency requirements and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1AF8?
SPE2DR26F1AF8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1AF8 worth?
The government has obligated $12,438 on SPE2DR26F1AF8.
Is contract SPE2DR26F1AF8 an order under another contract?
Yes. SPE2DR26F1AF8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AF8 competed?
The extent of competition for SPE2DR26F1AF8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award